Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ: EKSO · Real-Time Price · USD
0.4370
-0.0017 (-0.39%)
At close: Mar 28, 2025, 4:00 PM
0.4298
-0.0072 (-1.65%)
After-hours: Mar 28, 2025, 7:50 PM EDT
-0.39%
Market Cap 10.85M
Revenue (ttm) 17.93M
Net Income (ttm) -11.33M
Shares Out 24.82M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 86,671
Open 0.4304
Previous Close 0.4387
Day's Range 0.4130 - 0.4380
52-Week Range 0.3440 - 1.5300
Beta 1.43
Analysts Strong Buy
Price Target 5.00 (+1,044.17%)
Earnings Date Mar 3, 2025

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort... [Read more]

Sector Healthcare
Founded 2005
Employees 66
Stock Exchange NASDAQ
Ticker Symbol EKSO
Full Company Profile

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price forecast is $5.0, which is an increase of 1,044.17% from the latest price.

Price Target
$5.0
(1,044.17% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Stephen Kilmer - IR Jerome Wong - Chief Financial Officer Scott Davis - Chief ...

26 days ago - Seeking Alpha

Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results

SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and indust...

26 days ago - GlobeNewsWire

Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

4 weeks ago - GlobeNewsWire

NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry

Move expected to broaden access to Ekso Bionics' portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges across the United States Move expected to br...

6 weeks ago - GlobeNewsWire

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19

SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

4 months ago - GlobeNewsWire

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference

SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

4 months ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome...

5 months ago - Seeking Alpha

Ekso Bionics Announces Third Quarter 2024 Financial Results

SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today rep...

5 months ago - GlobeNewsWire

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024

SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

5 months ago - GlobeNewsWire

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering

SAN RAFAEL, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...

7 months ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...

8 months ago - Seeking Alpha

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024

SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...

8 months ago - GlobeNewsWire

Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024

SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

8 months ago - GlobeNewsWire

Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors

Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso's Board

10 months ago - GlobeNewsWire

Artificial Intelligence in the Global Prosthetic Market 2024-2033, with Profiles of Ossur, Blatchford, Ottobock, Ekso Bionics, Open Bionics, Advanced Arm Dynamics and BrainRobotics

Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Prosthetic Market - A Global and Regional Analysis: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMark...

10 months ago - GlobeNewsWire

Ekso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew Pinsky

Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif.

11 months ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Results Conference Call April 29, 2023 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...

11 months ago - Seeking Alpha

Ekso Bionics Announces First Quarter 2024 Financial Results

SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and indust...

11 months ago - GlobeNewsWire

Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024

SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...

1 year ago - GlobeNewsWire

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and indust...

1 year ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...

1 year ago - Seeking Alpha

Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskelet...

1 year ago - GlobeNewsWire

Ekso Bionics Launches GaitCoach Software for EksoNR

SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

1 year ago - GlobeNewsWire

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

1 year ago - GlobeNewsWire

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...

1 year ago - GlobeNewsWire